Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
作者信息
Bast R, Woolas R
出版信息
BMJ. 1993 Jun 19;306(6893):1684-5. doi: 10.1136/bmj.306.6893.1684-b.
Abstract
摘要
相似文献
1
Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
BMJ. 1993 Jun 19;306(6893):1684-5. doi: 10.1136/bmj.306.6893.1684-b.
2
Ovarian cancer screening.卵巢癌筛查
Curr Opin Obstet Gynecol. 1994 Feb;6(1):67-74.
3
4
Ovarian cancer screening.
Hematol Oncol Clin North Am. 2003 Aug;17(4):989-1005, ix. doi: 10.1016/s0889-8588(03)00063-7.
5
A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
Arch Gynecol Obstet. 1995;256(1):9-15. doi: 10.1007/BF00634342.
6
Screening for early ovarian cancer.早期卵巢癌筛查
Br J Hosp Med. 1992;48(8):454-9.
7
CA-125 as a screening test for ovarian cancer.
JAMA. 1993;269(24):3106-7.
8
Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546.
Int J Gynecol Cancer. 2005 Jan-Feb;15(1):37-44. doi: 10.1111/j.1048-891X.2005.15004.x.
9
[CA-12 tumor marker values in serum following radioimmuno-scintigraphy].
Gynakol Rundsch. 1990;30 Suppl 1:72-3.
10
Sialyl Tn as a prognostic marker in epithelial ovarian cancer.唾液酸Tn作为上皮性卵巢癌的预后标志物
Br J Cancer. 1992 Nov;66(5):984-5. doi: 10.1038/bjc.1992.397.
引用本文的文献
1
Proteomics in cancer screening and management in gynecologic cancer.蛋白质组学在妇科癌症筛查与管理中的应用
Curr Oncol Rep. 2004 Nov;6(6):456-62. doi: 10.1007/s11912-004-0076-4.
本文引用的文献
1
Screening for ovarian cancer.卵巢癌筛查
BMJ. 1993 Apr 17;306(6884):1015-6. doi: 10.1136/bmj.306.6884.1015.
2
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer.血清CA 125水平用于卵巢癌早期检测的前瞻性评估。
Obstet Gynecol. 1992 Jul;80(1):14-8.
Zotero 插件